Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer
Clinical trial NCT02289690 · COMPLETED
Trial details
- NCT number
- NCT02289690
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2019-04-17
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.